newsfilter
← Latest News
Business Wire·

Aerie Pharmaceuticals Announces Presentations at the Association for Research in Vision and Ophthalmology Annual Meeting in Denver, Colorado, May 1-4, 2022

Abstracts showcase Rhopressa®/netarsudil, AR-15512 and "ROCK'Ster" Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a pharmaceutical company focused on the discovery, development and commercialization of first-in-class ophthalmic therapies, today announce